NewslettersNeural Cell NewsUncategorizedSTAT3 Is a Biologically Relevant Therapeutic Target in H3K27M-Mutant Diffuse Midline GliomaBy Justin.choi - April 13, 2022066Researchers screened a library of drugs either FDA-approved or in clinical trial using a library of patient-derived H3K27M-mutant diffuse midline glioma cell lines with cell viability as the outcome.[Neuro-Oncology] 6445212 AAAAAAAA items 1 apa 0 default asc 1 174042 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Abstract